CellWell record HH-460289
Serum Potassium and Mineralocorticoid Receptor Antagonists As Modifiers of Atrial Arrhythmia Recurrence After Catheter Ablation for Atrial Fibrillation: A Narrative Review With Systematic Search and Mechanistic Synthesis
Shunichiro Tomita; Takuya Kishi
2026
In plain language
This review found limited, low-quality evidence that serum potassium and mineralocorticoid receptor antagonists affect atrial fibrillation recurrence after ablation, including a U-shaped potassium association, and does not support routine supplementation or antagonist use for that purpose.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-460289
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.